ESTRO Multidisciplinary Management of Breast Cancer 2017

Previous Page

Next Page

Page Background

Treatments (neo)-adjuvant setting

Chemotherapy (e.g)

• Taxanes

• Anthracyclines

• Cyclophosphamide

Endocrine therapy (ER+ and/or PR+ tumors)

• Tamoxifen

• Aromatase-inhibitors

Trastuzumab +/- Pertuzumab (HER2+ tumor)

19-9-2017